Lin, Y. 2022. Kinase inhibitor therapies for Chronic lymphocytic leukaemia (CLL): SYK, BTK and PI3K inhibitors. Highlights in Science, Engineering and Technology. 19, (Nov. 2022), 30–35. DOI:https://doi.org/10.54097/hset.v19i.2691.